Biopterin metabolism and nitric oxide recoupling in cancer

Tetrahydrobiopterin is a cofactor necessary for the activity of several enzymes, the most studied of which is nitric oxide synthase. The role of this cofactor-enzyme relationship in vascular biology is well established. Recently, tetrahydrobiopterin metabolism has received increasing attention in th...

Full description

Bibliographic Details
Main Authors: Gene Chatman Clark, Alan Lai, Aashri Agarwal, Zheng Liu, Xiang-Yang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1321326/full
_version_ 1797295132976873472
author Gene Chatman Clark
Gene Chatman Clark
Alan Lai
Aashri Agarwal
Zheng Liu
Zheng Liu
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
author_facet Gene Chatman Clark
Gene Chatman Clark
Alan Lai
Aashri Agarwal
Zheng Liu
Zheng Liu
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
author_sort Gene Chatman Clark
collection DOAJ
description Tetrahydrobiopterin is a cofactor necessary for the activity of several enzymes, the most studied of which is nitric oxide synthase. The role of this cofactor-enzyme relationship in vascular biology is well established. Recently, tetrahydrobiopterin metabolism has received increasing attention in the field of cancer immunology and immunotherapy due to its involvement in the cytotoxic T cell response. Past research has demonstrated that when the availability of BH4 is low, as it is in chronic inflammatory conditions and tumors, electron transfer in the active site of nitric oxide synthase becomes uncoupled from the oxidation of arginine. This results in the production of radical species that are capable of a direct attack on tetrahydrobiopterin, further depleting its local availability. This feedforward loop may act like a molecular switch, reinforcing low tetrahydrobiopterin levels leading to altered NO signaling, restrained immune effector activity, and perpetual vascular inflammation within the tumor microenvironment. In this review, we discuss the evidence for this underappreciated mechanism in different aspects of tumor progression and therapeutic responses. Furthermore, we discuss the preclinical evidence supporting a clinical role for tetrahydrobiopterin supplementation to enhance immunotherapy and radiotherapy for solid tumors and the potential safety concerns.
first_indexed 2024-03-07T21:42:19Z
format Article
id doaj.art-36c3eb1b3b5548b485d0b4c9f5fcf7a2
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-07T21:42:19Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-36c3eb1b3b5548b485d0b4c9f5fcf7a22024-02-26T04:50:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011310.3389/fonc.2023.13213261321326Biopterin metabolism and nitric oxide recoupling in cancerGene Chatman Clark0Gene Chatman Clark1Alan Lai2Aashri Agarwal3Zheng Liu4Zheng Liu5Xiang-Yang Wang6Xiang-Yang Wang7Xiang-Yang Wang8Department of Biochemistry, Virginia Commonwealth University, Richmond, VA, United StatesSchool of Medicine, Virginia Commonwealth University, Richmond, VA, United StatesSchool of Medicine, Virginia Commonwealth University, Richmond, VA, United StatesCornell University, Ithaca, NY, United StatesDepartment of Human Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United StatesMassey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesDepartment of Human Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United StatesMassey Cancer Center, Virginia Commonwealth University, Richmond, VA, United StatesInstitute of Molecular Medicine, Virginia Commonwealth University, Richmond, VA, United StatesTetrahydrobiopterin is a cofactor necessary for the activity of several enzymes, the most studied of which is nitric oxide synthase. The role of this cofactor-enzyme relationship in vascular biology is well established. Recently, tetrahydrobiopterin metabolism has received increasing attention in the field of cancer immunology and immunotherapy due to its involvement in the cytotoxic T cell response. Past research has demonstrated that when the availability of BH4 is low, as it is in chronic inflammatory conditions and tumors, electron transfer in the active site of nitric oxide synthase becomes uncoupled from the oxidation of arginine. This results in the production of radical species that are capable of a direct attack on tetrahydrobiopterin, further depleting its local availability. This feedforward loop may act like a molecular switch, reinforcing low tetrahydrobiopterin levels leading to altered NO signaling, restrained immune effector activity, and perpetual vascular inflammation within the tumor microenvironment. In this review, we discuss the evidence for this underappreciated mechanism in different aspects of tumor progression and therapeutic responses. Furthermore, we discuss the preclinical evidence supporting a clinical role for tetrahydrobiopterin supplementation to enhance immunotherapy and radiotherapy for solid tumors and the potential safety concerns.https://www.frontiersin.org/articles/10.3389/fonc.2023.1321326/fulltetrahydrobiopterinradiotherapynitric oxide synthaseimmunotherapyimmunometabolismvascular normalization
spellingShingle Gene Chatman Clark
Gene Chatman Clark
Alan Lai
Aashri Agarwal
Zheng Liu
Zheng Liu
Xiang-Yang Wang
Xiang-Yang Wang
Xiang-Yang Wang
Biopterin metabolism and nitric oxide recoupling in cancer
Frontiers in Oncology
tetrahydrobiopterin
radiotherapy
nitric oxide synthase
immunotherapy
immunometabolism
vascular normalization
title Biopterin metabolism and nitric oxide recoupling in cancer
title_full Biopterin metabolism and nitric oxide recoupling in cancer
title_fullStr Biopterin metabolism and nitric oxide recoupling in cancer
title_full_unstemmed Biopterin metabolism and nitric oxide recoupling in cancer
title_short Biopterin metabolism and nitric oxide recoupling in cancer
title_sort biopterin metabolism and nitric oxide recoupling in cancer
topic tetrahydrobiopterin
radiotherapy
nitric oxide synthase
immunotherapy
immunometabolism
vascular normalization
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1321326/full
work_keys_str_mv AT genechatmanclark biopterinmetabolismandnitricoxiderecouplingincancer
AT genechatmanclark biopterinmetabolismandnitricoxiderecouplingincancer
AT alanlai biopterinmetabolismandnitricoxiderecouplingincancer
AT aashriagarwal biopterinmetabolismandnitricoxiderecouplingincancer
AT zhengliu biopterinmetabolismandnitricoxiderecouplingincancer
AT zhengliu biopterinmetabolismandnitricoxiderecouplingincancer
AT xiangyangwang biopterinmetabolismandnitricoxiderecouplingincancer
AT xiangyangwang biopterinmetabolismandnitricoxiderecouplingincancer
AT xiangyangwang biopterinmetabolismandnitricoxiderecouplingincancer